Crinetics Pharmaceuticals
The Talent & Development Manager leads key talent programs and initiatives that support employee development, organizational capability, and a high-performing, inclusive culture.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2008
Crinetics Pharmaceuticals, now a Vertex Pharmaceuticals company, is a pharmaceutical company dedicated to discovering, developing, and commercializing treatments for endocrine diseases. Based in San Diego, CA, the company maintains a pipeline of novel therapies including Paltusotine (an oral SST2 agonist) and Atumelnant (an oral ACTH antagonist). Crinetics aims to be the premier endocrine-rooted global pharmaceutical company, focused on improving the lives of patients with endocrine disorders.
Crinetics Pharmaceuticals Highlights Early PALSONIFY Sales, EU Milestone, and GPCR Pipeline at TD Cowen Conf.
3 days ago
WINTON GROUP Ltd Takes Position in Crinetics Pharmaceuticals, Inc. $CRNX
1 day ago
Will Crinetics Pharmaceuticals Inc. stock attract more institutional investors - Insider Buying & High Win Rate Trade Alerts
4 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Crinetics Pharmaceuticals.
3% below the average for this role
Why Crinetics Pharmaceuticals (CRNX) Is Down 7.1% After Deeper 2025 Loss And New US$207 Million Shelf Registration
1 week ago